Biotechnology Stocks I Performance Guide: BeiGene, Ltd. (BGNE)
BGNE has no dividends.
Table and Chart of BGNE Performance
See what a $1,000 investment in BGNE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| BGNE Returns | |
|---|---|
| Start Date | Mar-31-2016 |
| Start Price | $29.31 |
| End Date | May-17-2024 |
| End Price | $172.85 |
| # Prices | 99 |
| Min Date | Jul-29-2016 |
| Min Price | $26.24 |
| Max Date | Sep-30-2021 |
| Max Price | $363.00 |
| Total Return | 489.73% |
| Annualized Return | 24.00% |
| Current Value of $1,000 Purchase | $5,897 |
| Number Returns | 4,851 |
| Average Return | 163.93% |
| Number Profitable Returns | 3,663 |
| Percent Profitable Returns | 75.51% |
| Number Unprofitable Returns | 1,188 |
| Percent Unprofitable Returns | 24.49% |
| Profitable to Unprofitable Returns Ratio | 3.08 |
| BGNE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $19,606,202,000 |
| Beta | 0.626 | Price to Sales | 6.34 |
| Earnings per Share | $-7.5400 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 4.174 |
| PRICE DATA | |
| 52 Week High | $245.74 |
| 52 Week Low | $126.97 |
| Analyst Target Price | $270.99 |
| 50-Day Moving Average | $155.41 |
| 200-Day Moving Average | $173.39 |
| FINANCIAL DATA | |
| Revenue per Share | $26.46 |
| Revenue | $2,762,630,000 |
| Profit Margin | -28.4% |
| Return on Equity | -20.9% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
BGNE Compare Returns with S&P 500
BGNE Trendline Chart
BGNE Moving Average Chart
BGNE Stock Return Map - See Patterns of Gains and Losses
BGNE Stock Returns/Purchase Dates